Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06467292

Speech Motor Learning and Retention (Master Protocol)

Sensorimotor Basis of Speech Motor Learning and Retention

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
330 (estimated)
Sponsor
Yale University · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The overall goal of this research is to test a new model of speech motor learning, whose central hypothesis is that learning and retention are associated with plasticity not only in motor areas of the brain but in auditory and somatosensory regions as well.

Detailed description

Aim 1 involves tests of speech motor memory retention following disruption of left hemisphere brain activity in either auditory, somatosensory or motor cortex or to a control site (hand area motor cortex right hemisphere). Continuous theta-burst stimulation (cTBS) is delivered following adaptation to altered auditory feedback to assess its effects on the retention of new learning. Aim 2 assesses the temporal order in which plasticity occurs in cortical motor and sensory brain areas during speech motor learning. In Aim 3, resting-state fMRI will be interleaved with speech motor adaptation. For information specific to each aim, please refer to the below corresponding, separate, clinicaltrials.gov records: unique IDs: 2000037622\_a for Aim 1, 2000037622\_b for Aim 2 and 2000037622\_c for Aim 3.

Conditions

Interventions

TypeNameDescription
DEVICEcontinuous theta-burst stimulation (cTBS)cTBS stimulation will be applied to different areas of the brain following learning. Stimulation will take place following learning in order to block motor memory retention.
BEHAVIORALAdaptationAuditory adaptation in speech
DEVICESingle pulse Transcranial magnetic stimulation (TMS)TMS will be delivered 10 times in each motor evoked potentials (MEP) recording block.
DEVICEfMRITo assess functional connectivity patterns between regions that predict learning.

Timeline

Start date
2024-10-01
Primary completion
2028-11-30
Completion
2029-05-31
First posted
2024-06-21
Last updated
2026-02-19

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06467292. Inclusion in this directory is not an endorsement.